Back to the main directory
Company Analysis / Equity
- BASILEA PHARMACEUTICA: FY feedback: Derazantinib poised to become the most versatile FGFR inhibitor around | BUY | CHF95 vs. CHF78 (+59%) by Bryan Garnier
- EUROBIO SCIENTIFIC - Marquage CE test coronavirus Seegene (+) by MidCap Partners
- CAMPARI: Disappointing Q4 results and uninspiring 2020 guidance | NEUTRAL | EUR8.7(-2%) by Bryan Garnier
- ATOS: Unsurprising FY19 results, free cash flow and FY20 guidance | BUY - Top Picks | EUR107(+32%) by Bryan Garnier
- HBL_CY19 Results Review, (AKD, Off the Analyst's Desk, Feb 19, 2020) by AKD Securities Limited
- INDU: 1HFY20 Result Review, (AKD, Off the Analyst's Desk, Feb 19, 2020) by AKD Securities Limited
- UBL_CY19 Result Review, (AKD, Off the Analyst's Desk, Feb 19, 2020) by AKD Securities Limited
- Pixium Vision - Wrapping up 2019 with a solid financial position by Edison Investment Research
- Allied Minds - Federated moving towards commercialisation by Edison Investment Research
- Leclanché - Convertible loan from Yorkville Advisors by Edison Investment Research
- 6PM Call: Pennies shines by Viet Dragon Securities
- MOSL: Morning India (20/February/20): 1. Voices (Mixed commentary; short-term respite not visible yet!); 2. Hero MotoCorp (R&D ramp up to accelerate transformation) by Motilal Oswal
- FOCUS HOME INTERACTIVE - Saber : pas d’impact à CT et MT, à priori (+) by MidCap Partners
- Daily Market briefing - West African Regional Stock Exchange by Hudson & Cie
- Diversified Gas & Oil - Strong hedging programme supporting cash flows by Edison Investment Research
- NEXTEDIA - CA 2019: 24,4 M€, +8,6%, en ligne - Opinion Achat - Objectif: 1,06 € (vs 1,11€) - Potentiel:+46% by GreenSome Finance
- Research Note - Eyemaxx Real Estate AG - 20.02.20 by GBC AG
- XILAM - 2019 Revenue (-) Short Term Frustrations by MidCap Partners
- ALTEN BUY | EUR123 FY19 meeting feedback: the picture still looks good by Bryan Garnier
- BOUYGUES NEUTRAL | EUR39 Exceptional dividend alongside good FY 2019 results by Bryan Garnier
- ACCOR BUY | EUR47 FY results: Sustained as expected. Health crisis hard to measure by Bryan Garnier
- GENMAB BUY | DKK1900 vs. DKK1700 Higher-than.expected 2020 OPEX guidance could be good entry point by Bryan Garnier
- SCHNEIDER ELECTRIC BUY | Under review Solid Q4, positive outlook and reassuring comments on China by Bryan Garnier
- Research Comment - Media and Games Invest plc - 20.02.20 by GBC AG
- 4Q19 preliminary results review by Ipopema Securities
- GLAXOSMITHKLINE: Two years to wait before the "new GSK" | NEUTRAL | 1773p(+7%) by Bryan Garnier
- FOCUS HOME INTERACTIVE - Saber Bought by Embracer: That’s Enough… (-) by MidCap Partners
- CAPGEMINI - BUY | EUR135 Acquisition of Advectas by Bryan Garnier
- Newsletter Janvier 2020 by AfricaBourse
- ADUX - CA+EBITDA 2019: Résultats supérieurs aux attentes - Opinion Achat - Objectif: 2,22 € (vs 1,69€) - Potentiel:+19,4% by GreenSome Finance
- Agnico Eagle Mines - Record production and cash flow by Edison Investment Research
- Quadrise Fuels International - Pursuing opportunities in multiple sectors by Edison Investment Research
- ZTO: Cautious On 1H2020 Due To Negative Impacts From Outbreak Of Coronavirus by T.H. Capital
- Fidelity China Special Situations - Weak sentiment providing opportunities by Edison Investment Research
- MOSL: VOICES | INDIA INC ON CALL- Mixed commentary; short-term respite not visible yet! by Motilal Oswal
- Analyst Pin-board: Which opportunities for DRC in 2020? by Viet Dragon Securities
- by AKD Securities Limited
- DALET - CA 2019 (+) 2019 en ligne, très bonnes perspectives pour 2020 by MidCap Partners
- PLASTIC OMNIUM - Renforcement des fondamentaux dans un secteur en berne (=) by MidCap Partners
- FOCUS HOME INTERACTIVE - Saber: A Priori, No ST/MT Impact (+) by MidCap Partners
- DALET - 2019 Revenue (+) 2019 In Line, Very Good Prospects for 2020 by MidCap Partners
- PLASTIC OMNIUM - Strengthening the Fundamentals in a Sector at Half-Mast (=) by MidCap Partners
- AXA BUY - TOP PICKS | EUR33 We continue to like AXA’s new profile by Bryan Garnier
- ATOS BUY - Top Picks | EUR105 vs. EUR107 FY19 call feedback: Spring comes in the midst of winter by Bryan Garnier
- BE SEMICONDUCTOR BUY - Top Picks | EUR39 Strong Q4 results with improving momentum; China casts some uncertainty, as expected by Bryan Garnier
- DIALOG SEMICONDUCTOR BUY | EUR53 Dialog acquisition of Adesto Technologies looks interesting by Bryan Garnier
- UCB BUY | EUR90 Strong FY 2019 results as expected by Bryan Garnier
- 24h sur les Actions - Actualité des marchés actions - 20/02/2020 by Aurel BGC
- Research Comment english - Media and Games Invest plc - 20.02.20 by GBC AG
- Pakistan Commodities: Turbulence prevails as food inflation creeps higher, (AKD Daily, Feb 20, 2020) by AKD Securities Limited